Moderna, Inc. Common Stock (MRNA) Financials
Key financial figures for Moderna, Inc. Common Stock (Q2 2026).
- Revenue
- $145M
- Net Income
- -$782M
- EPS
- $-1.97
- Total Assets
- $11.0B
- Operating Cash Flow
- -$526M
Full income statement, balance sheet, and cash flow for Moderna, Inc. Common Stock on SentiSense.